Blood cancers, Cell type, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 3
This trial looked at adding copanlisib to rituximab and chemotherapy. It was for people with certain types of non-Hodgkin lymphoma that had come back after treatment.
The trial was open for people to join between 2016 and 2020. The team published the results in 2021 and 2024.
Recruitment start: 19 April 2016
Recruitment end: 31 March 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Ruth Pettengell
Bayer
Last reviewed: 21 May 2025
CRUK internal database number: 13632
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
